Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131898) titled 'Clinical Study on Qihong Tongnao Mixture in the Treatment of Acute Ischemic Stroke (Qi Deficiency and Blood Stasis Syndrome)' on Sept. 7.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine

Condition: Cerebral arterial thrombosis

Intervention: Trial group:Conventional Western medicine-based basic treatment + Qihong Tongna Compound

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-07

Target Sample Size: Trial group:54;Control group:54;

Countries of Recruitmen...